John Flavin
Fondateur chez PYXIS ONCOLOGY, INC.
Fortune : 1 M $ au 31/05/2024
Postes actifs de John Flavin
Sociétés | Poste | Début | Fin |
---|---|---|---|
PYXIS ONCOLOGY, INC. | Fondateur | 11/06/2018 | - |
Président | 11/06/2018 | - | |
Independent Dir/Board Member | 11/12/2019 | - | |
Directeur/Membre du Conseil | 11/12/2019 | - | |
Flavin Ventures LLC | Corporate Officer/Principal | 04/01/2010 | - |
Portal Innovations LLC
Portal Innovations LLC Investment ManagersFinance Portal Innovations LLC (Portal Innovations) is a venture capital firm founded in 2020 by John L. Flavin. The firm is headquartered in Chicago, Illinois. | Directeur Général | 01/03/2022 | - |
Fondateur | 01/03/2020 | - | |
ClostraBio, Inc.
ClostraBio, Inc. BiotechnologyHealth Technology ClostraBio, Inc. develops microbiome-modulating therapeutics. It creates a drug that aims to prevent allergic reactions to food. The firm is dedicated to understanding and treating food allergies and other diseases of the immune system. The company was founded by Cathryn R. Nagler and Jeffrey A. Hubbell and is headquartered in Chicago, IL. | Président | - | - |
Historique de carrière de John Flavin
Anciens postes connus de John Flavin
Sociétés | Poste | Début | Fin |
---|---|---|---|
Endotronix, Inc.
Endotronix, Inc. Medical SpecialtiesHealth Technology Endotronix, Inc. develops wireless heart sensor technology. The firm has introduced the Cordella Heart Failure System, a comprehensive solution for heart failure management. The company was founded by Anthony I. Nunez and Harry D. Rowland in June 2007 and is headquartered in Lisle, IL. | Directeur Financier/CFO | 01/04/2018 | 01/02/2020 |
ADVANCED LIFE SCIENCES HOLDINGS, INC. | Directeur/Membre du Conseil | 01/06/2002 | 05/05/2011 |
Directeur Financier/CFO | 05/05/2011 | 05/05/2011 | |
President | - | 05/05/2011 | |
Secrétaire Général | 05/05/2011 | 05/05/2011 | |
MediChem Life Sciences, Inc.
MediChem Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of DGI Resolution, Inc., MediChem Life Sciences, Inc. provides research and drug discovery services. The company is based in Woodridge, IL. The company was founded in 1987 by Michael T. Flavin. MediChem Life Sciences was acquired by deCODE genetics, Inc. on March 18, 2002 for $52.85 million. | Directeur des opérations | 01/05/2000 | 01/05/2002 |
Directeur Financier/CFO | 01/01/1991 | 01/05/2000 | |
President | 01/01/1991 | 01/05/2000 | |
Advanced X-Ray Analytical Services, Inc. | President | - | - |
ThermoGen, Inc.
ThermoGen, Inc. Medical SpecialtiesHealth Technology ThermoGen, Inc. develops biocatalysts for pharmaceutical production. The company was headquartered in Chicago, IL. | President | - | - |
░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - | - |
Formation de John Flavin
Lewis University | Masters Business Admin |
Marquette University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 13 |
Opérationnelle
President | 5 |
Director of Finance/CFO | 3 |
Director/Board Member | 2 |
Sectorielle
Health Technology | 6 |
Commercial Services | 3 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
PYXIS ONCOLOGY, INC. | Health Technology |
Entreprise privées | 9 |
---|---|
MediChem Life Sciences, Inc.
MediChem Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of DGI Resolution, Inc., MediChem Life Sciences, Inc. provides research and drug discovery services. The company is based in Woodridge, IL. The company was founded in 1987 by Michael T. Flavin. MediChem Life Sciences was acquired by deCODE genetics, Inc. on March 18, 2002 for $52.85 million. | Commercial Services |
Advanced Life Sciences Holdings, Inc.
Advanced Life Sciences Holdings, Inc. BiotechnologyHealth Technology Advanced Life Sciences Holdings, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel drugs in therapeutic areas of infection, cancer and inflammation. Its product candidate, Restanza, is a novel once-a-day oral antibiotic in late-stage development for the treatment of life-threatening infections including community-aquired bacterial pneumonia and biodefense pathogens including anthrax, plague and tularemia. The company was founded by Michael T. Flavin on January 1, 1999 and is headquartered in Woodridge, IL. | Health Technology |
Endotronix, Inc.
Endotronix, Inc. Medical SpecialtiesHealth Technology Endotronix, Inc. develops wireless heart sensor technology. The firm has introduced the Cordella Heart Failure System, a comprehensive solution for heart failure management. The company was founded by Anthony I. Nunez and Harry D. Rowland in June 2007 and is headquartered in Lisle, IL. | Health Technology |
Emerald BioStructures, Inc.
Emerald BioStructures, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beryllium LLC, Emerald BioStructures, Inc. is a company that offers products and services in protein X-ray crystallography, specializing in the area of protein crystallization. The company is based in Bainbridge Island, WA. The company was founded by Lance K. Stewart. Emerald BioStructures was acquired by MediChem Research, Inc. on May 31, 2000. | Commercial Services |
ThermoGen, Inc.
ThermoGen, Inc. Medical SpecialtiesHealth Technology ThermoGen, Inc. develops biocatalysts for pharmaceutical production. The company was headquartered in Chicago, IL. | Health Technology |
Flavin Ventures LLC | |
Advanced X-Ray Analytical Services, Inc. | |
ClostraBio, Inc.
ClostraBio, Inc. BiotechnologyHealth Technology ClostraBio, Inc. develops microbiome-modulating therapeutics. It creates a drug that aims to prevent allergic reactions to food. The firm is dedicated to understanding and treating food allergies and other diseases of the immune system. The company was founded by Cathryn R. Nagler and Jeffrey A. Hubbell and is headquartered in Chicago, IL. | Health Technology |
Portal Innovations LLC
Portal Innovations LLC Investment ManagersFinance Portal Innovations LLC (Portal Innovations) is a venture capital firm founded in 2020 by John L. Flavin. The firm is headquartered in Chicago, Illinois. | Finance |
- Bourse
- Insiders
- John Flavin
- Expérience